Tag Archives: PRTA

Hot High Tech Stocks To Buy Right Now

The Dow Jones today jumped 57 points in pre-market trading after Facebook Inc. (Nasdaq: FB) posted better-than-expected earnings. Facebook beat revenue estimates by 4% and announced that it had increased its workforce by 48%. Much of the market expected Facebook to report losses on the heels of the multiple scandals that plagued the company throughout the first quarter.

With earnings season in full swing, there’s no better time to adopt a new trading strategy. Money Morning Quantitative Specialist Chris Johnson argues that the markets are at a tipping point. And with just a few smart plays in today’s classic “stock-picker’s market”… you can pull in triple-digit gains with just a small investment. Read those picks, right here.

Here are the numbers from Wednesday for the Dow, S&P 500, and Nasdaq:

Index Previous Close Point Change Percentage Change
Dow Jones 24,083.83 59.70 0.25%
Nasdaq 7,003.74 -3.61 -0.05
S&P 500 2,639.40 4.84 0.18%

Now here’s a closer look at today’s Money Morning insight, the most important market events, and stocks to watch.

Hot High Tech Stocks To Buy Right Now: Prothena Corporation plc(PRTA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Prothena Corporation plc (NASDAQ: PRTA) shares dipped 69 percent to $11.48 after a disappointing update relating to the company's treatment for AL amyloidosis. Prothena, a clinical-stage biopharmaceutical company that focuses on therapies in the neuroscience and orphan categories, said a Phase 2b study of its therapy called NEOD001 failed to achieve its primary or secondary endpoints. Prothena's Phase 2b study explored its NEOD001 therapy versus a placebo in previously-treated patients with AL amyloidosis and persistent cardiac dysfunction.
    Gridsum Holding Inc. (NASDAQ: GSUM) fell 44.3 percent to $4.06. Gridsum reported suspension of audit report on financial statements.
    Flotek Industries, Inc. (NYSE: FTK) shares declined 34.1 percent to $4.16 as the company issued weak revenue forecast for the first quarter.
    Akorn, Inc. (NASDAQ: AKRX) dropped 32.3 percent to $13.35 after Fresenius terminated its merger deal with Akorn.
    Chicago Bridge & Iron Company N.V. (NYSE: CBI) fell 31.2 percent to $13.44. Subsea 7 made an unsolicited bid to buy McDermott for $7 per share. However, the acquisition offer is contingent on McDermot terminating its pending merger with Chicago Bridge & Iron.
    Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS) dropped 18 percent to $5.76. Controladora Vuela recently reported first-quarter results that showed a loss for the quarter. Imperial Capital downgraded Controladora Vuela Compania de Aviacion from Outperform to In-Line.
    Atossa Genetics Inc. (NASDAQ: ATOS) fell 18.2 percent to $2.8797 after declining 19.35 percent on Friday.
    Alcoa Corporation (NYSE: AA) fell 12.3 percent to $52.63.
    Luby's, Inc. (NYSE: LUB) shares declined 10.3 percent to $2.448 following Q2 results.
    Aceto Corporation (NASDAQ: ACET) shares tumbled 10 percent to $2.26.
    Pier 1 Imports, Inc. (NYSE: PIR) dipped 9.7 percent

  • [By Max Byerly]

    Royal Bank of Canada reduced its stake in Prothena Co. PLC (NASDAQ:PRTA) by 40.0% during the first quarter, Holdings Channel reports. The fund owned 7,337 shares of the biotechnology company’s stock after selling 4,888 shares during the period. Royal Bank of Canada’s holdings in Prothena were worth $269,000 as of its most recent SEC filing.

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By Cory Renauer]

    April’s been a month of biotech bloodbaths. In a 15-day span, Incyte Corporation (NASDAQ:INCY), Prothena Corporation PLC (NASDAQ:PRTA), and Celldex Therapeutics Inc. (NASDAQ:CLDX) have all reported clinical trial failures that have hammered their stock prices.

  • [By Lisa Levin]

    Prothena Corporation plc (NASDAQ: PRTA) shares dropped 68 percent to $11.79 after a disappointing update relating to the company's treatment for AL amyloidosis. Prothena, a clinical-stage biopharmaceutical company that focuses on therapies in the neuroscience and orphan categories, said a Phase 2b study of its therapy called NEOD001 failed to achieve its primary or secondary endpoints. Prothena's Phase 2b study explored its NEOD001 therapy versus a placebo in previously-treated patients with AL amyloidosis and persistent cardiac dysfunction. Unfortunately, there were no statistically significant difference between the two treatment groups.

  • [By Lisa Levin]

    Prothena Corporation plc (NASDAQ: PRTA) shares dropped 69 percent to $11.585 after a disappointing update relating to the company's treatment for AL amyloidosis. Prothena, a clinical-stage biopharmaceutical company that focuses on therapies in the neuroscience and orphan categories, said a Phase 2b study of its therapy called NEOD001 failed to achieve its primary or secondary endpoints. Prothena's Phase 2b study explored its NEOD001 therapy versus a placebo in previously-treated patients with AL amyloidosis and persistent cardiac dysfunction. Unfortunately, there were no statistically significant difference between the two treatment groups.

Hot High Tech Stocks To Buy Right Now: BlackLine, Inc. (BL)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    The period-end close is a time-consuming and frustrating process that accountants in nearly every business have to deal with on a regular basis. BlackLine (NASDAQ:BL) is a software-as-a-service provider that brings order to this chaotic affair through automation. Businesses everywhere have been flocking to the service in an effort to bring their accounting process into the 21st century.

  • [By Brian Feroldi]

    There’s also a ton of room for niche applications for these businesses. One of the companies that we’ve touched on a few weeks ago when I was on the show was BlackLine (NASDAQ:BL). They have targeted this niche of real-time accounting software, which is something that not many other companies are going after. So, there is plenty of room, I think, for smaller players that take a more niche focus to succeed.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on BlackLine (BL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Keith Speights, Sean Williams, and Brian Feroldi]

    We asked three Motley Fool contributors to identify which small-cap stocks they like right now. They picked cloud-based software provider Blackline (NASDAQ:BL), up-and-coming biotech Supernus Pharmaceuticals (NASDAQ:SUPN), and cannabis distributor Origin House (NASDAQOTH:ORHOF). Here’s why these three small-cap stocks especially stand out.

Hot High Tech Stocks To Buy Right Now: Timken Steel Corporation(TMST)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Timkensteel (TMST)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Timkensteel (NYSE: TMST) and APERAM/SH N Y REGISTRY SH (OTCMKTS:APEMY) are both basic materials companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, dividends, institutional ownership, profitability and earnings.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on TimkenSteel (TMST)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Timkensteel (TMST)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Value Stocks For 2019

Snapchat is a great product with strong engagement levels. However, SNAP stock is overvalued at thecurrent level.
Flickr

Yesterday, the self-described “camera company” Snap Inc (NYSE:SNAP) went public in what was one of the most successful IPO listings in the past few years. Pushing aside all the valuation concerns, Snap shares listed on NYSE at a price of $24, more than 40% above its offer price of $17. After hitting a high of $26.05, Snap stockclosed the day at $24.48, 44% above its initial price. So, if you are one of those people who held SNAP stock before it started trading on NYSE, congratulations! In all, more than 217 million shares of SNAP changed hands. Snap Inc raised more money through its IPO than all of the tech IPOs combined in 2016.

Best Value Stocks For 2019: HSBC Holdings plc(HSBC)

Advisors’ Opinion:

  • [By Max Byerly]

    HSBC (NYSE: HSBC) and Kearny Financial (NASDAQ:KRNY) are both finance companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings.

  • [By Garrett Baldwin]

    Eight Seconds… $1,260 Richer: Words can’t describe what you’ll see in this shocking footage – because you’ll witness, live on camera, one man become $4,238 richer with just three clicks of a mouse. And if you follow the simple instructions in this video, you’ll learn how to set yourself up for an instant $2,918 payday opportunity. You need to see this to believe it…

    Three Stocks to Watch Today: COP, HD, HSBC
    ConocoPhillips (NYSE: COP) has seized assets from the Venezuelan-owned firm PDVSA in the Caribbean. The company won a court case that will allow it to take over assets owned by the Venezuelan government. The court enabled the seizures as part of a broader plan to allow the firm to recoup roughly $2 billion following the 2007 nationalization of its assets in Venezuela by the huge Castro-led government.
    Monday will be a quiet day on the earnings front. Investors are looking to Tuesday’s calendar, when The Home Depot Inc. (NYSE: HD) reports earnings. Tomorrow, Wall Street analysts expect that Home Depot will report earnings per share of $2.07 on top of $25.2 billion in revenue. Investors will be hoping that the company reports strong profits thanks to an improving U.S. economy and the recent tax reform law.
    Expect a lot of chatter today about blockchain technology. That’s because ING Bank and HSBC Holdings Plc.(NYSE: HSBC) announced over the weekend that they engaged in their first trade ever using blockchain technology. The two engaged in a trade on behalf of Cargill to finance a shipment of soybeans from Argentina to Malaysia.
    Today, look for earnings reports from Agilent Technologies (NYSE: A), Itron Inc.(Nasdaq: ITRI), Vipshop Holdings Ltd.(Nasdaq: VIPS), Amyris Biotechnologies Inc. (Nasdaq: AMRS), Sky Solar Holdings Ltd.(Nasdaq: SKYS), Mazor Robotics Ltd.(Nasdaq: MZOR), China Lodging Group Ltd. (Nasdaq: HTHT), and Mimecast Ltd.(Nasdaq: MIME).

    FollowMoney MorningonFacebook,Twitter, andLinkedIn.

  • [By Matthew Cochrane]

    In Kenya, 28 million consumers can now seamlessly integrate their M-Pesa accounts with PayPal. In Spain, CaixaBank and Bankia both further integrated their online sites with PayPal. HSBC Holdings PLC (NYSE:HSBC) now allows corporate customers in the U.K. to pay distributions to beneficiaries through PayPal, a capability to be rolled out across Europe in the coming months. Barclays PLC (NYSE:BCS) announced a strategic partnership that enables its customers to more easily link their accounts to PayPal, and soon to use their reward points on PayPal’s digital platform.

Best Value Stocks For 2019: Prothena Corporation plc(PRTA)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Turtle Beach Corporation (NASDAQ: HEAR) surged 87.1 percent to $12.98 after the company reported Q1 results and raised its FY18 outlook.
    ARMO BioSciences, Inc. (NASDAQ: ARMO) shares jumped 66.8 percent to $49.735 after Eli Lilly and Company (NYSE: LLY) announced plans to acquire ARMO BioSciences for $50 per share.
    vTv Therapeutics Inc. (NASDAQ: VTVT) gained 34 percent to $2.2920 following announcement that the company will pre-specify new subgroup with the FDA and report Phase 3 Part B results in June.
    Prestige Brands Holdings, Inc. (NYSE: PBH) climbed 22.3 percent to $34.84 after the company posted upbeat Q4 earnings.
    Depomed, Inc. (NASDAQ: DEPO) shares jumped 22.2 percent to $7.28 following better-than-expected Q1 earnings.
    Everspin Technologies, Inc. (NASDAQ: MRAM) gained 19.8 percent to $8.89 after the company reported strong results for its first quarter.
    Luxfer Holdings PLC (NYSE: LXFR) surged 19.8 percent to $17.10 following Q1 results.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 18.3 percent to $2.26 after French company Total announced plans to acquire 25 percent stake in Clean Energy Fuels for $83.4 million.
    Intelligent Systems Corporation (NYSE: INS) gained 17 percent to $7.116.
    Green Dot Corporation (NYSE: GDOT) surged 15.3 percent to $73.00 after reporting upbeat Q1 earnings.
    The Chefs' Warehouse, Inc. (NASDAQ: CHEF) climbed 15 percent to $28.85. Chefs' Warehouse posted Q1 earnings of $0.03 per share on sales of $318.6 million.
    Westport Fuel Systems Inc. (NASDAQ: WPRT) rose 14.2 percent to $2.9701.
    Wright Medical Group N.V. (NASDAQ: WMGI) jumped 13.8 percent to $23.87 after reporting upbeat quarterly earnings.
    Diplomat Pharmacy, Inc. (NYSE: DPLO) gained 13.4 percent to $22.70. Diplomat named Brian Griffin as Chairman and CEO.
    Carvana Co. (NYSE: CVNA) shares rose 13 percent to $27.97 after reporting upbeat Q1 sales.
    Prothena Corporation plc (NASDAQ: PRTA) gained 12 percent to $15.19
  • [By Jon C. Ogg]

    Creating a treatment for a rare disease or rare disorder can come with massive upside if the treatment is successful. That said, the risk is that a company can implode if its rare disease treatment fails in a drug study. Now it looks as if Prothena Corporation plc (NASDAQ: PRTA) is on the verge of implosion based upon how its stock price reacted.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Prothena Corporation plc (NASDAQ: PRTA) shares dipped 69 percent to $11.48 after a disappointing update relating to the company's treatment for AL amyloidosis. Prothena, a clinical-stage biopharmaceutical company that focuses on therapies in the neuroscience and orphan categories, said a Phase 2b study of its therapy called NEOD001 failed to achieve its primary or secondary endpoints. Prothena's Phase 2b study explored its NEOD001 therapy versus a placebo in previously-treated patients with AL amyloidosis and persistent cardiac dysfunction.
    Gridsum Holding Inc. (NASDAQ: GSUM) fell 44.3 percent to $4.06. Gridsum reported suspension of audit report on financial statements.
    Flotek Industries, Inc. (NYSE: FTK) shares declined 34.1 percent to $4.16 as the company issued weak revenue forecast for the first quarter.
    Akorn, Inc. (NASDAQ: AKRX) dropped 32.3 percent to $13.35 after Fresenius terminated its merger deal with Akorn.
    Chicago Bridge & Iron Company N.V. (NYSE: CBI) fell 31.2 percent to $13.44. Subsea 7 made an unsolicited bid to buy McDermott for $7 per share. However, the acquisition offer is contingent on McDermot terminating its pending merger with Chicago Bridge & Iron.
    Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS) dropped 18 percent to $5.76. Controladora Vuela recently reported first-quarter results that showed a loss for the quarter. Imperial Capital downgraded Controladora Vuela Compania de Aviacion from Outperform to In-Line.
    Atossa Genetics Inc. (NASDAQ: ATOS) fell 18.2 percent to $2.8797 after declining 19.35 percent on Friday.
    Alcoa Corporation (NYSE: AA) fell 12.3 percent to $52.63.
    Luby's, Inc. (NYSE: LUB) shares declined 10.3 percent to $2.448 following Q2 results.
    Aceto Corporation (NASDAQ: ACET) shares tumbled 10 percent to $2.26.
    Pier 1 Imports, Inc. (NYSE: PIR) dipped 9.7 percent

Best Value Stocks For 2019: The Navigators Group, Inc.(NAVG)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Shares of Navigators Group Inc (NASDAQ:NAVG) reached a new 52-week high and low on Tuesday . The company traded as low as $61.74 and last traded at $60.65, with a volume of 1347 shares trading hands. The stock had previously closed at $61.60.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Hertz Global Holdings, Inc. (NYSE: HTZ) is projected to post quarterly loss at $1.31 per share on revenue of $1.97 billion.
    International Flavors & Fragrances Inc. (NYSE: IFF) is estimated to post quarterly earnings at $1.59 per share on revenue of $909.36 million.
    Zillow Group, Inc. (NASDAQ: ZG) is expected to post quarterly earnings at $0.06 per share on revenue of $294.79 million.
    General Cable Corporation (NYSE: BGC) is estimated to post quarterly earnings at $0.15 per share on revenue of $980.61 million.
    Central Garden & Pet Company (NASDAQ: CENT) is expected to post quarterly earnings at $0.84 per share on revenue of $598.45 million.
    Cabot Corporation (NYSE: CBT) is estimated to post quarterly earnings at $1 per share on revenue of $746.42 million.
    Fabrinet (NYSE: FN) is expected to post quarterly earnings at $0.71 per share on revenue of $319.71 million.
    National General Holdings Corp. (NASDAQ: NGHC) is projected to post quarterly earnings at $0.55 per share on revenue of $1.08 billion.
    The Navigators Group, Inc. (NASDAQ: NAVG) is estimated to post quarterly earnings at $0.75 per share on revenue of $320.92 million.
    Diplomat Pharmacy, Inc. (NYSE: DPLO) is expected to post quarterly earnings at $0.22 per share on revenue of $1.29 billion.
    Trex Company, Inc. (NYSE: TREX) is projected to post quarterly earnings at $1.19 per share on revenue of $172.22 million.
    AMC Entertainment Holdings, Inc. (NYSE: AMC) is expected to post quarterly earnings at $0.09 per share on revenue of $1.35 billion.
    Envision Healthcare Corporation (NYSE: EVHC) is projected to post quarterly earnings at $0.64 per share on revenue of $2.02 billion.
    Regal Beloit Corporation (NYSE: RBC) is estimated to post quarterly earnings at $1.23 per share on revenue of $869.64 million.
    Amedisys, Inc. (NASDAQ: AMED) is projected to post quarterly earnings at $0.67 per share on revenue of $39

  • [By Stephan Byrd]

    Russell Investments Group Ltd. grew its holdings in shares of Navigators Group Inc (NASDAQ:NAVG) by 9.2% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 68,797 shares of the insurance provider’s stock after purchasing an additional 5,796 shares during the period. Russell Investments Group Ltd. owned approximately 0.23% of Navigators Group worth $3,966,000 at the end of the most recent reporting period.

Best Value Stocks For 2019: Energy Select Sector SPDR ETF (XLE)

Advisors’ Opinion:

  • [By Logan Wallace]

    Slate Path Capital LP purchased a new position in Energy Select Sector SPDR (NYSEARCA:XLE) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,500,000 shares of the exchange traded fund’s stock, valued at approximately $101,115,000. Energy Select Sector SPDR accounts for approximately 6.5% of Slate Path Capital LP’s investment portfolio, making the stock its 6th biggest position. Slate Path Capital LP owned about 0.60% of Energy Select Sector SPDR as of its most recent SEC filing.

  • [By ]

    Markets were mixed on Wednesday and then surged higher in afternoon trading, led by the energy sector as oil prices rose following President Trump’s withdrawal from the Iran nuclear deal. Exxon Mobile (XOM) and Chevron (CVX) led the way, and the Energy Select Sector SPDR Fund  (XLE)  posted solid gains.

  • [By Ethan Ryder]

    Traders sold shares of Energy Select Sector SPDR Fund (NYSEARCA:XLE) on strength during trading hours on Thursday. $150.97 million flowed into the stock on the tick-up and $236.14 million flowed out of the stock on the tick-down, for a money net flow of $85.17 million out of the stock. Of all stocks tracked, Energy Select Sector SPDR Fund had the 0th highest net out-flow for the day. Energy Select Sector SPDR Fund traded up $0.09 for the day and closed at $73.65

  • [By Jim Crumly]

    Energy stocks fell on lower oil prices, but transportation stocks gained. TheEnergy Select Sector SPDR ETF (NYSEMKT:XLE) dropped 1.6%, and theiShares Transportation Average ETF (NYSEMKT:IYT) rose 1.1%.

Best Value Stocks For 2019: Capital Southwest Corporation(CSWC)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Capital Southwest Co. (NASDAQ:CSWC) announced a quarterly dividend on Tuesday, June 5th, Wall Street Journal reports. Investors of record on Tuesday, June 26th will be paid a dividend of 0.29 per share by the asset manager on Monday, July 2nd. This represents a $1.16 annualized dividend and a dividend yield of 6.80%. The ex-dividend date of this dividend is Monday, June 25th. This is a boost from Capital Southwest’s previous quarterly dividend of $0.28.

  • [By Motley Fool Staff]

    Capital Southwest (NASDAQ:CSWC) Q4 2018 Earnings Conference CallJun. 5, 2018 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Max Byerly]

    Capital Southwest (NASDAQ: CSWC) and TRIPLEPOINT VEN/COM (NYSE:TPVG) are both small-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations.

Top 5 Gold Stocks To Buy Right Now

Angel Commodities’ report on Gold

Last week, spot gold prices declined 0. 4 percent to trade at $ 1311.2 per ounce while MCX gold prices declined 0.6 percent although rupee depreciation of around 2 percent did not help gold prices much. Stronger US dollar optimistic data sets from the US and assurance from the FED that the rate hikes will be gradual in 2018 kept the gold prices in check for most of the last week. The Fed said inflation on a 12 – month basis was “expected to run near the committee’s symmetric 2 percent objective”. However, sharp downside was limited as u ncertainties supported bullion, including U.S. – China trade talks and the potential U.S. withdrawal from the Iranian nuclear accord.

Outlook
We expect gold prices to trade higher today as the Iranian nuclear accord and the US China trade tensions will boost safe haven demand. On the MCX, gold prices are expected to trade higher today, international markets are trading higher by 0.2 percent at $ 1317.70 per ounce.

For all commodities report, click here

Top 5 Gold Stocks To Buy Right Now: Cray Inc(CRAY)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Cray (CRAY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Staff]

    Gardner:There’sa lot of biotech and some computer companies. We once visited the Cray Corporation (NASDAQ:CRAY), which was one of the early supercomputer companies.Seymour Cray was one of the pioneers of supercomputing. If you look up Cray Computers, they were the supercomputers back in the 80s, when computers were a lot bigger than they are today, andprobably slower, but they were super back then. Anyway,that was a Minneapolis company I once visited. Our dad used to take us, occasionally, on trips. We’d just drop by corporate headquarters and talk to an investor relations person. That was one of the times I did that. Itwasn’t like I did it dozens of times. We did maybe five or six times. ButI’ll always remember Cray Computer.

Top 5 Gold Stocks To Buy Right Now: Investment Technology Group, Inc.(ITG)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Investment Technology Group (NYSE:ITG) announced a quarterly dividend on Thursday, May 17th, RTT News reports. Investors of record on Wednesday, May 30th will be given a dividend of 0.07 per share by the financial services provider on Friday, June 15th. This represents a $0.28 dividend on an annualized basis and a yield of 1.23%.

  • [By Max Byerly]

    SEI Investments (NASDAQ: SEIC) and Investment Technology Group (NYSE:ITG) are both finance companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, risk and institutional ownership.

Top 5 Gold Stocks To Buy Right Now: Check Point Software Technologies Ltd.(CHKP)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Check Point Software Technologies (CHKP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    Check Point Software Technologies (Nasdaq: CHKP) plummeted 6.4% when it only slightly beat Q1 expectations but guided lower for the year. Cybersecurity has gotten more competitive recently, and the company reported a 12% increase in marketing expenses through the first quarter. That spooked investors on the potential for slower sales growth and weaker profitability.

  • [By Ethan Ryder]

    Earnest Partners LLC lessened its position in shares of Check Point Software Technologies Ltd. (NASDAQ:CHKP) by 0.6% in the first quarter, according to its most recent filing with the SEC. The firm owned 968,317 shares of the technology company’s stock after selling 6,007 shares during the quarter. Earnest Partners LLC’s holdings in Check Point Software Technologies were worth $96,193,000 at the end of the most recent quarter.

Top 5 Gold Stocks To Buy Right Now: Brown Forman Corporation(BF.B)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Brown-Forman Co. Class B (NYSE:BF.B) issued an update on its FY19 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $1.75-1.85 for the period, compared to the Thomson Reuters consensus estimate of $1.83. The company issued revenue guidance of $3.44-3.48 billion (+6-7%), compared to the consensus revenue estimate of $3.46 billion.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Brown-Forman Co. Class B (BF.B)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Brown-Forman (BF.B)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Brown-Forman (BF.B)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Brown-Forman Co. Class B (NYSE:BF.B) issued an update on its FY19 earnings guidance on Wednesday morning. The company provided EPS guidance of $1.75-1.85 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.83. The company issued revenue guidance of $3.44-3.48 billion (+6-7%), compared to the consensus revenue estimate of $3.46 billion.

Top 5 Gold Stocks To Buy Right Now: Prothena Corporation plc(PRTA)

Advisors’ Opinion:

  • [By Brian Feroldi]

    In response to announcingthat it is stopping all clinical development of its lead product candidate,Prothena(NASDAQ:PRTA), a clinical-stage biotech focused onneuroscience andorphandiseases, saw its shares fall 69% as of 11 a.m. EDT.

  • [By Jon C. Ogg]

    Creating a treatment for a rare disease or rare disorder can come with massive upside if the treatment is successful. That said, the risk is that a company can implode if its rare disease treatment fails in a drug study. Now it looks as if Prothena Corporation plc (NASDAQ: PRTA) is on the verge of implosion based upon how its stock price reacted.

  • [By Paul Ausick]

    Prothena Corp. plc (NASDAQ: PRTA) traded down 70% Monday to post a new 52-week low of $11.05 after closing Friday at $36.84. The stock’s 52-week high is $70.00. Volume was more than 20 times the daily average of around 580,000 shares. The company is stopping development on an amyloidosis treatment following a failed late-stage trial.

  • [By Lisa Levin] Gainers
    Turtle Beach Corporation (NASDAQ: HEAR) surged 87.1 percent to $12.98 after the company reported Q1 results and raised its FY18 outlook.
    ARMO BioSciences, Inc. (NASDAQ: ARMO) shares jumped 66.8 percent to $49.735 after Eli Lilly and Company (NYSE: LLY) announced plans to acquire ARMO BioSciences for $50 per share.
    vTv Therapeutics Inc. (NASDAQ: VTVT) gained 34 percent to $2.2920 following announcement that the company will pre-specify new subgroup with the FDA and report Phase 3 Part B results in June.
    Prestige Brands Holdings, Inc. (NYSE: PBH) climbed 22.3 percent to $34.84 after the company posted upbeat Q4 earnings.
    Depomed, Inc. (NASDAQ: DEPO) shares jumped 22.2 percent to $7.28 following better-than-expected Q1 earnings.
    Everspin Technologies, Inc. (NASDAQ: MRAM) gained 19.8 percent to $8.89 after the company reported strong results for its first quarter.
    Luxfer Holdings PLC (NYSE: LXFR) surged 19.8 percent to $17.10 following Q1 results.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 18.3 percent to $2.26 after French company Total announced plans to acquire 25 percent stake in Clean Energy Fuels for $83.4 million.
    Intelligent Systems Corporation (NYSE: INS) gained 17 percent to $7.116.
    Green Dot Corporation (NYSE: GDOT) surged 15.3 percent to $73.00 after reporting upbeat Q1 earnings.
    The Chefs' Warehouse, Inc. (NASDAQ: CHEF) climbed 15 percent to $28.85. Chefs' Warehouse posted Q1 earnings of $0.03 per share on sales of $318.6 million.
    Westport Fuel Systems Inc. (NASDAQ: WPRT) rose 14.2 percent to $2.9701.
    Wright Medical Group N.V. (NASDAQ: WMGI) jumped 13.8 percent to $23.87 after reporting upbeat quarterly earnings.
    Diplomat Pharmacy, Inc. (NYSE: DPLO) gained 13.4 percent to $22.70. Diplomat named Brian Griffin as Chairman and CEO.
    Carvana Co. (NYSE: CVNA) shares rose 13 percent to $27.97 after reporting upbeat Q1 sales.
    Prothena Corporation plc (NASDAQ: PRTA) gained 12 percent to $15.19

Top Stocks To Watch For 2018

Litecoin prices fell 20% after a wave of new investors helped push the price above $100 yesterday (Nov. 29, 2017).

The price of Bitcoin also fell below $9,500 just a day after hitting an all-time high of $11,395. A dramatic sell-off across the entire cryptocurrency market shed more than $50 billion in total market capitalization.

The sharp downturn came shortly after two major exchanges reported a huge surge in traffic, which created a series of bugs and disabled trading across networks.

Joining in on the crusade against cryptocurrencies, economist Joseph Stiglitz argued that Bitcoin’s lack of oversight and potential use in illegal activities should draw greater regulatory scrutiny.

Top Stocks To Watch For 2018: Safety Insurance Group Inc.(SAFT)

Advisors’ Opinion:

  • [By Jordan Wathen]

    Safety Insurance Group (NASDAQ:SAFT) reported that winter weather activity and an accounting change were drags on its first-quarter results, though a lower tax rate was a net positive to the Massachusetts-based insurance company.

Top Stocks To Watch For 2018: Prothena Corporation plc(PRTA)

Advisors’ Opinion:

  • [By Paul Ausick]

    Prothena Corp. plc (NASDAQ: PRTA) traded down 70% Monday to post a new 52-week low of $11.05 after closing Friday at $36.84. The stock’s 52-week high is $70.00. Volume was more than 20 times the daily average of around 580,000 shares. The company is stopping development on an amyloidosis treatment following a failed late-stage trial.

  • [By Chris Lange]

    Prothena Corp. PLC (NASDAQ: PRTA) shares hit a multiyear low on Monday, one not seen since 2013. This came on the heels of news that the company would be discontinuing development of NEOD001, an investigational antibody that was being evaluated for the treatment of AL amyloidosis.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Prothena Corporation plc (NASDAQ: PRTA) shares dipped 69 percent to $11.48 after a disappointing update relating to the company's treatment for AL amyloidosis. Prothena, a clinical-stage biopharmaceutical company that focuses on therapies in the neuroscience and orphan categories, said a Phase 2b study of its therapy called NEOD001 failed to achieve its primary or secondary endpoints. Prothena's Phase 2b study explored its NEOD001 therapy versus a placebo in previously-treated patients with AL amyloidosis and persistent cardiac dysfunction.
    Gridsum Holding Inc. (NASDAQ: GSUM) fell 44.3 percent to $4.06. Gridsum reported suspension of audit report on financial statements.
    Flotek Industries, Inc. (NYSE: FTK) shares declined 34.1 percent to $4.16 as the company issued weak revenue forecast for the first quarter.
    Akorn, Inc. (NASDAQ: AKRX) dropped 32.3 percent to $13.35 after Fresenius terminated its merger deal with Akorn.
    Chicago Bridge & Iron Company N.V. (NYSE: CBI) fell 31.2 percent to $13.44. Subsea 7 made an unsolicited bid to buy McDermott for $7 per share. However, the acquisition offer is contingent on McDermot terminating its pending merger with Chicago Bridge & Iron.
    Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS) dropped 18 percent to $5.76. Controladora Vuela recently reported first-quarter results that showed a loss for the quarter. Imperial Capital downgraded Controladora Vuela Compania de Aviacion from Outperform to In-Line.
    Atossa Genetics Inc. (NASDAQ: ATOS) fell 18.2 percent to $2.8797 after declining 19.35 percent on Friday.
    Alcoa Corporation (NYSE: AA) fell 12.3 percent to $52.63.
    Luby's, Inc. (NYSE: LUB) shares declined 10.3 percent to $2.448 following Q2 results.
    Aceto Corporation (NASDAQ: ACET) shares tumbled 10 percent to $2.26.
    Pier 1 Imports, Inc. (NYSE: PIR) dipped 9.7 percent

Top Stocks To Watch For 2018: Banner Corporation(BANR)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Here are some of the news articles that may have impacted Accern’s rankings:

    Get Banner alerts:

    Banner Year for Asset Managers Could Be Catalyst for Change (markets.financialcontent.com) Zacks: Analysts Anticipate Banner Co. (BANR) to Announce $0.86 EPS (americanbankingnews.com) Banner Bank signs long lease for highly visible Sacramento site (finance.yahoo.com) Steven W. Rust Sells 511 Shares of Banner Co. (BANR) Stock (americanbankingnews.com) FY2018 Earnings Estimate for Banner Co. (BANR) Issued By DA Davidson (americanbankingnews.com)

    NASDAQ BANR opened at $57.47 on Friday. The company has a quick ratio of 0.90, a current ratio of 0.92 and a debt-to-equity ratio of 0.24. The firm has a market cap of $1,896.48, a P/E ratio of 19.22, a PEG ratio of 1.66 and a beta of 0.96. Banner has a 1 year low of $52.07 and a 1 year high of $62.75.

Top Stocks To Watch For 2018: Concert Pharmaceuticals, Inc.(CNCE)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Teachers Advisors LLC boosted its position in Concert Pharmaceuticals (NASDAQ:CNCE) by 293.9% during the fourth quarter, Holdings Channel reports. The fund owned 135,399 shares of the biotechnology company’s stock after purchasing an additional 101,026 shares during the quarter. Teachers Advisors LLC’s holdings in Concert Pharmaceuticals were worth $3,503,000 at the end of the most recent quarter.

Top Stocks To Watch For 2018: Moneygram International, Inc.(MGI)

Advisors’ Opinion:

  • [By ]

    Moneygram (MGI) : “No, you need quality and this one doesn’t have it.”

    Monster Beverage (MNST) : “I think this one has run out of gas so I’m going to say don’t buy. “

  • [By ]

    Cramer was bearish on Xilinx (XLNX) , Celgene (CELG) , Exelixis (EXEL) , Moneygram (MGI) , Monster Beverage (MNST) , SunCoke Energy Partners (SXCP) and Mattel (MAT) .

Top Stocks To Watch For 2018: Fogo de Chao, Inc.(FOGO)

Advisors’ Opinion:

  • [By Dustin Parrett]

    But with a VQScore of 4, our top score, this company is one of the best stocks you can buy right now, which means the Raymond James rating might be too conservative. Not only are you getting a company with growth potential, you’re getting it at an excellent price.

    Restaurant Stocks to Buy, No. 2: Fogo de Chao Inc. (Nasdaq: FOGO)

    Fogo de Chao Inc. (Nasdaq: FOGO) is upscale Brazilian steakhouse, originally opened in Brazil in 1979. Fogo de Chao currently has 47 restaurants across the world.

Top 5 Undervalued Stocks For 2018

LM Ericsson Telephone (ERIC)

Welcome. In this article I will give the dollar and cents reasons for how come ERIC looks like a relative bargain in today’s marketplace.

Story

In the trailing ten years ERIC has earned their market cap in free cash flow. This is a signal the company may be undervalued. If ERIC can repeat the performance and earn over $19B in the coming ten years. In a market where many companies are being valued at twice or three times as much free cash flow as they’ve generated over the trailing ten years, this factor alone makes ERIC a relative bargain.

Top 5 Undervalued Stocks For 2018: Prothena Corporation plc(PRTA)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Creating a treatment for a rare disease or rare disorder can come with massive upside if the treatment is successful. That said, the risk is that a company can implode if its rare disease treatment fails in a drug study. Now it looks as if Prothena Corporation plc (NASDAQ: PRTA) is on the verge of implosion based upon how its stock price reacted.

  • [By Paul Ausick]

    Prothena Corp. plc (NASDAQ: PRTA) traded down 70% Monday to post a new 52-week low of $11.05 after closing Friday at $36.84. The stock’s 52-week high is $70.00. Volume was more than 20 times the daily average of around 580,000 shares. The company is stopping development on an amyloidosis treatment following a failed late-stage trial.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Prothena Corporation plc (NASDAQ: PRTA) shares dipped 69 percent to $11.48 after a disappointing update relating to the company's treatment for AL amyloidosis. Prothena, a clinical-stage biopharmaceutical company that focuses on therapies in the neuroscience and orphan categories, said a Phase 2b study of its therapy called NEOD001 failed to achieve its primary or secondary endpoints. Prothena's Phase 2b study explored its NEOD001 therapy versus a placebo in previously-treated patients with AL amyloidosis and persistent cardiac dysfunction.
    Gridsum Holding Inc. (NASDAQ: GSUM) fell 44.3 percent to $4.06. Gridsum reported suspension of audit report on financial statements.
    Flotek Industries, Inc. (NYSE: FTK) shares declined 34.1 percent to $4.16 as the company issued weak revenue forecast for the first quarter.
    Akorn, Inc. (NASDAQ: AKRX) dropped 32.3 percent to $13.35 after Fresenius terminated its merger deal with Akorn.
    Chicago Bridge & Iron Company N.V. (NYSE: CBI) fell 31.2 percent to $13.44. Subsea 7 made an unsolicited bid to buy McDermott for $7 per share. However, the acquisition offer is contingent on McDermot terminating its pending merger with Chicago Bridge & Iron.
    Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS) dropped 18 percent to $5.76. Controladora Vuela recently reported first-quarter results that showed a loss for the quarter. Imperial Capital downgraded Controladora Vuela Compania de Aviacion from Outperform to In-Line.
    Atossa Genetics Inc. (NASDAQ: ATOS) fell 18.2 percent to $2.8797 after declining 19.35 percent on Friday.
    Alcoa Corporation (NYSE: AA) fell 12.3 percent to $52.63.
    Luby's, Inc. (NYSE: LUB) shares declined 10.3 percent to $2.448 following Q2 results.
    Aceto Corporation (NASDAQ: ACET) shares tumbled 10 percent to $2.26.
    Pier 1 Imports, Inc. (NYSE: PIR) dipped 9.7 percent

  • [By Brian Feroldi]

    In response to announcingthat it is stopping all clinical development of its lead product candidate,Prothena(NASDAQ:PRTA), a clinical-stage biotech focused onneuroscience andorphandiseases, saw its shares fall 69% as of 11 a.m. EDT.

Top 5 Undervalued Stocks For 2018: Penumbra, Inc.(PEN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Penumbra (NYSE:PEN) released its quarterly earnings results on Tuesday. The company reported $0.06 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.02) by $0.08, Fidelity Earnings reports. Penumbra had a return on equity of 1.15% and a net margin of 3.65%. The business had revenue of $102.70 million for the quarter, compared to analysts’ expectations of $90.98 million. During the same quarter in the previous year, the firm posted ($0.10) earnings per share. The company’s revenue was up 40.3% compared to the same quarter last year.

Top 5 Undervalued Stocks For 2018: New Oriental Education & Technology Group, Inc.(EDU)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Sanmina Corp (NASDAQ: SANM) shares rose 15.2 percent to $31.90 in pre-market trading as the company reported stronger-than-expected earnings for its second quarter on Monday.
    Cadence Design Systems, Inc. (NASDAQ: CDNS) rose 12.4 percent to $41.30 in pre-market trading after the company posted upbeat Q1 results and issued a strong Q2 forecast.
    Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) rose 10.8 percent to $8.75 in pre-market trading.
    Mitel Networks Corporation (NASDAQ: MITL) rose 8.8 percent to $11.05 in pre-market trading after the company agreed to be acquired by affiliates of Searchlight Capital Partners for $2.0 billion.
    Galectin Therapeutics, Inc. (NASDAQ: GALT) rose 7.3 percent to $3.70 in pre-market trading.
    Riot Blockchain, Inc. (NASDAQ: RIOT) shares rose 6.9 percent to $7.00 in pre-market trading after declining 1.50 percent on Monday.
    Hallmark Financial Services, Inc. (NASDAQ: HALL) rose 6.5 percent to $10.68 in pre-market trading.
    Boot Barn Holdings, Inc. (NYSE: BOOT) rose 5.2 percent to $20.40 in pre-market trading after gaining 4.53 percent on Monday.
    New Oriental Education & Technology Group Inc. (NYSE: EDU) rose 5 percent to $91.16 in pre-market trading after reporting Q3 results.
    Shire plc (NASDAQ: SHPG) rose 5 percent to $167.98 in pre-market trading after Bloomberg reported that Takeda is nearing a preliminary agreement to acquire Shire after sweetened bid.
    Outfront Media Inc. (NYSE: OUT) shares rose 5 percent to $19.00 in pre-market trading.
    Geron Corporation (NASDAQ: GERN) rose 4.3 percent to $4.18 in pre-market trading after gaining 5.80 percent on Monday.
    SAP SE (NYSE: SAP) rose 3.7 percent to $109.80 in pre-market trading after the company posted strong quarterly results and raised its outlook for the year.
    Golden Ocean Group Limited (NASDAQ: GOGL) shares rose 3.7 percent to $8.70 in pre-market trading after gaining 1.45 percent on Monday.
    Deutsche Bank Aktiengesellschaft (NYSE: D
  • [By Motley Fool Staff]

    New Oriental Education & Technology Group (NYSE:EDU) Q3 2017 Earnings Conference CallApril 24, 2018 8:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Brian Stoffel]

    As the old saying goes, “You need to strike when the iron is hot.”Management at New Oriental Education & Technology Group(NYSE:EDU), a provider of in-person and online after-school tutoring in China, knows that the business is red-hot right now; it is striking by leveraging its balance sheet and growing brand by pushing a massive expansion throughout the Middle Kingdom.

  • [By Lisa Levin] Gainers
    SemiLEDs Corporation (NASDAQ: LEDS) shares rose 35.8 percent to $4.55.
    EVINE Live Inc. (NASDAQ: EVLV) gained 28.8 percent to $1.04. The pay-TV home shopping company was named as a potential acquisition target by TechCrunch. According to the publication, Amazon.com, Inc. (NASDAQ: AMZN) is exploring ways of marketing its products and services to consumers beyond the internet.
    Sanmina Corp (NASDAQ: SANM) shares surged 19.1 percent to $33.00 as the company reported stronger-than-expected earnings for its second quarter on Monday.
    Heidrick & Struggles International, Inc. (NASDAQ: HSII) gained 14.9 percent to $37.22 as the company posted upbeat results for its first quarter.
    Santander Consumer USA Holdings Inc. (NYSE: SC) shares climbed 14 percent to $17.90 following upbeat quarterly earnings.
    Helix Energy Solutions Group, Inc. (NYSE: HLX) climbed 14 percent to $7.12 following strong quarterly results.
    Check-Cap Ltd. (NASDAQ: CHEK) gained 13.6 percent to $8.25.
    Atossa Genetics Inc. (NASDAQ: ATOS) rose 11.8 percent to $3.34. Atossa Genetics disclosed that it has Received positive interim review from the Independent Safety Committee in Phase 1 Topical endoxifen dose escalation study in men.
    Cadence Design Systems, Inc. (NASDAQ: CDNS) gained 11.6 percent to $40.99 after the company posted upbeat Q1 results and issued a strong Q2 forecast.
    Genprex, Inc. (NASDAQ: GNPX) climbed 11.2 percent to $4.9363.
    Mitel Networks Corporation (NASDAQ: MITL) rose 10.5 percent to $11.23 after the company agreed to be acquired by affiliates of Searchlight Capital Partners for $2.0 billion.
    Systemax Inc. (NYSE: SYX) rose 10.2 percent to $30.86. Sidoti & Co. upgraded Systemax from Neutral to Buy.
    Orchids Paper Products Company (NYSE: TIS) surged 9.2 percent to $7.13. Orchids Paper Products is expected to report its Q1 financial results on Wednesday, April 25, 2018.
    New Oriental Education & Technology Group Inc. (NYSE: EDU) rose

Top 5 Undervalued Stocks For 2018: Norwegian Cruise Line Holdings Ltd.(NCLH)

Advisors’ Opinion:

  • [By ]

    Norwegian Cruise Line (NCLH) CEO Frank Del Rio tells TheStreet that 2018 bookings and pricing are very strong. Further, 2019 bookings and pricing are looking quite robust as well. 

  • [By ]

    Meanwhile, TheStreet will drop a podcast with Carnival Corp. (CCL) CEO Arnold Donald this weekend. Donald and I talked Wednesday afternoon about his rise to the top gig at Carnival and overall cruise line industry trends. Similar to what I learned from talking to Norwegisn Cruise Line (NCLH) CEO Frank Del Rio last week, I came away thinking Carnival is also undervalued here (stock is down 5% this year). While there are a good number of new ships hitting waters in 2019 and beyond, the consumer demand is such that more ships are warranted. Risks: surging oil prices (it takes a lot of fuel to run a cruise ship) and a recession (meaning somewhat empty new ships).

  • [By Dan Caplinger]

    The stock market once again proved its resiliency on Wednesday, bouncing back from extensive declines early in the session to recover most of its losses. The Dow Jones Industrials actually managed to post yet another record close with a modest gain, and although other major market benchmarks suffered declines, they weren’t significant. Moreover, some favorable news from certain pockets of the market helped bolster investor confidence. Toll Brothers (NYSE:TOL), Lantheus Holdings (NASDAQ:LNTH), and Norwegian Cruise Line Holdings (NASDAQ:NCLH) were among the top performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

  • [By ]

    TheStreet’s founder and Action Alerts PLUS Portfolio Manager Jim Cramer said Norwegian Cruise Line (NCLH) is a bargain for millennials.

    Cramer interviewed CEO Frank Del Rio on Thursday’s edition of CNBC’s Mad Money. 

  • [By ]

    Norwegian Cruise Line (NCLH) CEO Frank Del Rio tells me 2019 is off to a strong start and there are no signs in his business of a looming recession.

  • [By Monica Gerson]

    Norwegian Cruise Line Holdings Ltd (NASDAQ: NCLH) is expected to report its quarterly earnings at $0.37 per share on revenue of $1.10 billion.

    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is projected to post its quarterly earnings at $2.31 per share on revenue of $338.86 million.

Top 5 Undervalued Stocks For 2018: Apple Inc.(AAPL)

Advisors’ Opinion:

  • [By JJ Kinahan]

    This is one of the busiest weeks for earnings this quarter. In addition to TWTR and FB, there are quite a few other tech companies reporting this week. Amazon.com, Inc. (NASDAQ: AMZN), Microsoft Corporation (NASDAQ: MSFT) and Intel Corporation (NASDAQ: INTC) all report after market close on Thursday, Apr. 26. Next week, we’ll see a few other major tech reports with both Apple Inc. (NASDAQ: AAPL) and Alibaba Group Holding Ltd. (NYSE: BABA) on the docket.

  • [By Brett Hershman]

    A key reason for the success of many of the biggest companies in the world — Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL), Netflix, Inc. (NASDAQ: NFLX), Apple Inc. (NASDAQ: AAPL) and Facebook Inc (NASDAQ: FB) — is due to how much they know about consumer psychology. Amazon is no different, and their acquisition of Whole Foods will undoubtedly deepen the company's understanding of the consumer.

  • [By WWW.THESTREET.COM]

    Cramer and the AAP team view the strength of corporations as most important in proving that stocks can handle current valuations. Find out what they’re telling their investment club members about Arconic (ARNC) , Apple (AAPL) and Magellan Midstream Partners (MMP) . Get a free trial subscription to Action Alerts PLUS.

  • [By JJ Kinahan]

    The positive tone early Monday followed a fierce Friday rally that looked like a delayed reaction to what’s been an outstanding earnings season so far. Apple Inc. (NASDAQ: AAPL) earnings earlier in the week seemed to be the catalyst as that stock climbed more than 13 percent in five sessions to a new all-time high.

Top Casino Stocks To Invest In 2019

Federal investigators have halted an alleged student loan debt relief scam that bilked more than $11 million from consumers nationwide.

Strategic Student Solutions and several related companies falsely promised to reduce or eliminate student loan debt and also offered the borrowers non-existent credit repair services, in exchange for upfront fees and monthly payments, the Federal Trade Commission charged incourt papersmade public Thursday.

Although borrowers allegedly got no relief from their debts, Dave Green, owner of the companies, used corporate funds to pay for jewelry, casino tabs, mortgage payments, luxury vehicles and construction of a pool, the FTC charged.

.oembed-asset-link { border-bottom: 1px solid #e1e1e1; } .oembed-link-anchor { display: block; clear: both; } p.oembed-link-desc { font-size: 100%; color: #666; font-weight: normal; margin: 0 14px 14px 14px; font-family: ‘Futura Today Light’; text-align: left; line-height: 120%; }

FTC Complaint v Strategic Student Solutions

Top Casino Stocks To Invest In 2019: City Holding Company(CHCO)

Advisors’ Opinion:

  • [By Monica Gerson]

    City Holding Company (NASDAQ: CHCO) is expected to report its quarterly earnings at $0.74 per share on revenue of $42.04 million.

    Compass Minerals International, Inc. (NYSE: CMP) is projected to post its quarterly earnings at $1.33 per share on revenue of $347.03 million.

Top Casino Stocks To Invest In 2019: Richmont Mines, Inc.(RIC)

Advisors’ Opinion:

  • [By Sally Jones]

    Richmont Mines Inc. (RIC)

    Down 70% over 12 months, Richmont Mines Inc. has a market cap of $56.23 billion, and trades with a P/B of 0.60.

Top Casino Stocks To Invest In 2019: Prothena Corporation plc(PRTA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Prothena Corporation plc (NASDAQ: PRTA) shares dipped 69 percent to $11.48 after a disappointing update relating to the company's treatment for AL amyloidosis. Prothena, a clinical-stage biopharmaceutical company that focuses on therapies in the neuroscience and orphan categories, said a Phase 2b study of its therapy called NEOD001 failed to achieve its primary or secondary endpoints. Prothena's Phase 2b study explored its NEOD001 therapy versus a placebo in previously-treated patients with AL amyloidosis and persistent cardiac dysfunction.
    Gridsum Holding Inc. (NASDAQ: GSUM) fell 44.3 percent to $4.06. Gridsum reported suspension of audit report on financial statements.
    Flotek Industries, Inc. (NYSE: FTK) shares declined 34.1 percent to $4.16 as the company issued weak revenue forecast for the first quarter.
    Akorn, Inc. (NASDAQ: AKRX) dropped 32.3 percent to $13.35 after Fresenius terminated its merger deal with Akorn.
    Chicago Bridge & Iron Company N.V. (NYSE: CBI) fell 31.2 percent to $13.44. Subsea 7 made an unsolicited bid to buy McDermott for $7 per share. However, the acquisition offer is contingent on McDermot terminating its pending merger with Chicago Bridge & Iron.
    Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS) dropped 18 percent to $5.76. Controladora Vuela recently reported first-quarter results that showed a loss for the quarter. Imperial Capital downgraded Controladora Vuela Compania de Aviacion from Outperform to In-Line.
    Atossa Genetics Inc. (NASDAQ: ATOS) fell 18.2 percent to $2.8797 after declining 19.35 percent on Friday.
    Alcoa Corporation (NYSE: AA) fell 12.3 percent to $52.63.
    Luby's, Inc. (NYSE: LUB) shares declined 10.3 percent to $2.448 following Q2 results.
    Aceto Corporation (NASDAQ: ACET) shares tumbled 10 percent to $2.26.
    Pier 1 Imports, Inc. (NYSE: PIR) dipped 9.7 percent

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By Jon C. Ogg]

    Creating a treatment for a rare disease or rare disorder can come with massive upside if the treatment is successful. That said, the risk is that a company can implode if its rare disease treatment fails in a drug study. Now it looks as if Prothena Corporation plc (NASDAQ: PRTA) is on the verge of implosion based upon how its stock price reacted.

  • [By Brian Feroldi]

    In response to announcingthat it is stopping all clinical development of its lead product candidate,Prothena(NASDAQ:PRTA), a clinical-stage biotech focused onneuroscience andorphandiseases, saw its shares fall 69% as of 11 a.m. EDT.

  • [By Paul Ausick]

    Prothena Corp. plc (NASDAQ: PRTA) traded down 70% Monday to post a new 52-week low of $11.05 after closing Friday at $36.84. The stock’s 52-week high is $70.00. Volume was more than 20 times the daily average of around 580,000 shares. The company is stopping development on an amyloidosis treatment following a failed late-stage trial.

  • [By Lisa Levin]

    Prothena Corporation plc (NASDAQ: PRTA) shares dropped 69 percent to $11.43 after a disappointing update relating to the company's treatment for AL amyloidosis. Prothena, a clinical-stage biopharmaceutical company that focuses on therapies in the neuroscience and orphan categories, said a Phase 2b study of its therapy called NEOD001 failed to achieve its primary or secondary endpoints. Prothena's Phase 2b study explored its NEOD001 therapy versus a placebo in previously-treated patients with AL amyloidosis and persistent cardiac dysfunction. Unfortunately, there were no statistically significant difference between the two treatment groups.

Top 10 Stocks To Own Right Now

Facebook (NASDAQ:FB) has long been a stock that I wanted to purchase for my portfolio but have never done it till now. A little over a month ago I wrote an article about how the company has missed on some metrics, and as a result, I was willing to purchase the stock at $115 if it ever fell to that level by writing the November put, but the stock never reached that level by the expiration date. So, instead, I purchased a small position outright at the end of November and have some unrealized losses for now. Nevertheless, it is always important to remain vigilant in doing homework on the stocks one owns in their portfolio to see what else is happening.

There has been a broad selloff in tech stocks since December started, but Facebook has weathered the storm as the stock is flat in the last month. Investors have been selling off the tech plays because they are not considered to be a part of the Trump cohort of stocks which should thrive for the next four years. Trump has clearly stated his presidency will revolve around infrastructure spend, and because Facebook has nothing to do with infrastructure, investors have been using it as a source of funds to purchase the Trump related infrastructure plays.

Top 10 Stocks To Own Right Now: Cidara Therapeutics, Inc.(CDTX)

Advisors’ Opinion:

  • [By Chris Lange]

    Cidara Therapeutics Inc. (NASDAQ: CDTX) shares took a big step back on Monday, despite the firm reporting positive midstage results. Specifically, Cidara reported positive topline results from its Phase 2 Strive clinical trial of its lead antifungal candidate rezafungin acetate.

  • [By Lee Jackson]

    These companies also reported insider buying last week: Cidara Therapeutics Inc. (NASDAQ: CDTX), Ducommun Inc. (NYSE: DCO), HealthEquity Inc. (NASDAQ: HQY), Panhandle Oil and Gas Inc. (NYSE: PHX) and PolarityTE Inc. (NASDAQ: COOL).

Top 10 Stocks To Own Right Now: CYREN Ltd.(CYRN)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Tyson Foods, Inc. (NYSE: TSN) is expected to report quarterly earnings at $1.38 per share on revenue of $9.86 billion.
    Aecom (NYSE: ACM) is projected to report quarterly earnings at $0.71 per share on revenue of $4.67 billion.
    JD.Com Inc(ADR) (NASDAQ: JD) is estimated to report quarterly earnings at $0.11 per share on revenue of $12.60 billion.
    58.com Inc (ADR) (NYSE: WUBA) is projected to report quarterly earnings at $0.28 per share on revenue of $383.60 million.
    Kamada Ltd (NASDAQ: KMDA) is expected to report quarterly earnings at $0.02 per share on revenue of $25.00 million.
    Palatin Technologies, Inc. (NYSE: PTN) is projected to report quarterly earnings at $0.06 per share on revenue of $28.00 million.
    TheStreet, Inc. (NASDAQ: TST) is estimated to report a quarterly loss at $0.02 per share on revenue of $15.81 million.
    Atlantica Yield PLC (NASDAQ: ABY) is projected to report quarterly earnings at $0.45 per share on revenue of $290.80 million.
    Asure Software Inc (NASDAQ: ASUR) is estimated to report quarterly earnings at $0.15 per share on revenue of $15.26 million.
    Cyren Ltd (NASDAQ: CYRN) is expected to report quarterly loss at $0.06 per share on revenue of $7.90 million.
    Viewray Inc (NASDAQ: VRAY) is estimated to report quarterly loss at $0.12 per share on revenue of $18.58 million.

     

  • [By Lisa Levin]

    Shares of Cyren Ltd (NASDAQ: CYRN) got a boost, shooting up 41 percent to $2.33 after the company reported a strategic investment from Warburg Pincus Funds.

Top 10 Stocks To Own Right Now: Penske Automotive Group, Inc.(PAG)

Advisors’ Opinion:

  • [By Shane Hupp]

    Penske Automotive Group (NYSE: PAG) is one of 20 publicly-traded companies in the “Automotive dealers & gasoline service stations” industry, but how does it compare to its peers? We will compare Penske Automotive Group to similar companies based on the strength of its earnings, valuation, institutional ownership, dividends, analyst recommendations, risk and profitability.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Thermo Fisher Scientific Inc. (NYSE: TMO) is projected to report quarterly earnings at $2.4 per share on revenue of $5.63 billion.
    Ford Motor Company (NYSE: F) is expected to report quarterly earnings at $0.41 per share on revenue of $37.16 billion.
    Twitter, Inc. (NYSE: TWTR) is projected to report quarterly earnings at $0.11 per share on revenue of $605.26 million.
    Comcast Corporation (NASDAQ: CMCSA) is expected to report quarterly earnings at $0.59 per share on revenue of $22.75 billion.
    General Dynamics Corporation (NYSE: GD) is estimated to report quarterly earnings at $2.52 per share on revenue of $7.6 billion.
    The Boeing Company (NYSE: BA) is expected to report quarterly earnings at $2.58 per share on revenue of $22.24 billion.
    Anthem, Inc. (NYSE: ANTM) is estimated to report quarterly earnings at $4.91 per share on revenue of $22.52 billion.
    Viacom, Inc. (NASDAQ: VIAB) is projected to report quarterly earnings at $0.79 per share on revenue of $3.04 billion.
    Northrop Grumman Corporation (NYSE: NOC) is estimated to report quarterly earnings at $3.61 per share on revenue of $6.61 billion.
    Rockwell Automation Inc. (NYSE: ROK) is expected to report quarterly earnings at $1.81 per share on revenue of $1.66 billion.
    Wipro Limited (NYSE: WIT) is projected to report quarterly earnings at $0.07 per share on revenue of $2.15 billion.
    The Goodyear Tire & Rubber Company (NASDAQ: GT) is expected to report quarterly earnings at $0.46 per share on revenue of $3.82 billion.
    Owens Corning (NYSE: OC) is projected to report quarterly earnings at $0.97 per share on revenue of $1.62 billion.
    T. Rowe Price Group, Inc. (NASDAQ: TROW) is estimated to report quarterly earnings at $1.71 per share on revenue of $1.29 billion.
    Dr Pepper Snapple Group, Inc. (NYSE: DPS) is expected to report quarterly earnings at $1.04 per share on revenue of $1.57 billion.
    Sirius XM Holdings Inc. (NASDAQ: SI

Top 10 Stocks To Own Right Now: Synacor, Inc.(SYNC)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of INTEL CORP’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=INTEL+CORP

    These are the top 5 holdings of INTEL CORPCloudera Inc (CLDR) – 26,065,827 shares, 92.26% of the total portfolio. Borqs Technologies Inc (BRQS) – 3,799,172 shares, 5.42% of the total portfolio. ForeScout Technologies Inc (FSCT) – 257,756 shares, 1.37% of the total portfolio. Aquantia Corp (AQ) – 161,492 shares, 0.42% of the total portfolio. Synacor Inc (SYNC) – 866,884 shares, 0.23% of the total portfolio. New

  • [By Lisa Levin]

    Synacor Inc (NASDAQ: SYNC) shares dropped 18 percent to $3.42. Synacor priced 5.715 million shares at $3.50 per share.

    Shares of Resources Connection, Inc. (NASDAQ: RECN) were down around 15 percent to $13.65 after the company posted downbeat quarterly results.

  • [By Monica Gerson]

    Synacor Inc (NASDAQ: SYNC) is projected to post a quarterly loss at $0.03 per share on revenue of $30.00 million.

    VAALCO Energy, Inc. (NYSE: EGY) is expected to post a quarterly loss at $0.11 per share on revenue of $18.59 million.

Top 10 Stocks To Own Right Now: Prothena Corporation plc(PRTA)

Advisors’ Opinion:

  • [By Cory Renauer]

    April’s been a month of biotech bloodbaths. In a 15-day span, Incyte Corporation (NASDAQ:INCY), Prothena Corporation PLC (NASDAQ:PRTA), and Celldex Therapeutics Inc. (NASDAQ:CLDX)have all reported clinical trial failures that have hammered theirstock prices.

  • [By Brian Feroldi]

    In response to announcingthat it is stopping all clinical development of its lead product candidate,Prothena(NASDAQ:PRTA), a clinical-stage biotech focused onneuroscience andorphandiseases, saw its shares fall 69% as of 11 a.m. EDT.

  • [By Lisa Levin]

    Prothena Corporation plc (NASDAQ: PRTA) shares dropped 69 percent to $11.43 after a disappointing update relating to the company's treatment for AL amyloidosis. Prothena, a clinical-stage biopharmaceutical company that focuses on therapies in the neuroscience and orphan categories, said a Phase 2b study of its therapy called NEOD001 failed to achieve its primary or secondary endpoints. Prothena's Phase 2b study explored its NEOD001 therapy versus a placebo in previously-treated patients with AL amyloidosis and persistent cardiac dysfunction. Unfortunately, there were no statistically significant difference between the two treatment groups.

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

Top 10 Stocks To Own Right Now: Hooker Furniture Corporation(HOFT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Hooker Furniture Corporation (NASDAQ: HOFT) shares were also up, gaining 27 percent to $39.80 after the company reported strong results for its fourth quarter.

  • [By Monica Gerson]

    Hooker Furniture Corporation (NASDAQ: HOFT) is estimated to report its quarterly earnings at $0.40 per share on revenue of $62.20 million.

    SeaChange International (NASDAQ: SEAC) is projected to post its quarterly earnings at $0.01 per share on revenue of $30.49 million.

Top 10 Stocks To Own Right Now: The Joint Corp.(JYNT)

Advisors’ Opinion:

  • [By Monica Gerson]

    Joint Corp (NASDAQ: JYNT) is estimated to post a quarterly loss at $0.28 per share on revenue of $4.13 million.

    Synacor Inc (NASDAQ: SYNC) is projected to post a quarterly loss at $0.03 per share on revenue of $30.00 million.

Top 10 Stocks To Own Right Now: Fitbit, Inc.(FIT)

Advisors’ Opinion:

  • [By Leo Sun]

    Under Armour (NYSE:UA) (NYSE:UAA), Fitbit (NYSE:FIT), and GoPro (NASDAQ:GPRO) were all terrible stocks to own over the past year. Under Armour and Fitbit were both cut in half, and GoPro plummeted nearly 40%.

  • [By Matthew Cochrane]

    In January 2016, Mastercard reached an agreement with the wearable payment platform Coin, in a collaboration to introduce more payment features in wearables. Since the collaboration, Coin was acquired by Fitbit Inc(NYSE:FIT), meaning Mastercard might have an early edge among payments companies to break into the wearable market in a big way.

  • [By Leo Sun]

    Fitbit (NYSE:FIT) recently announced an executive shakeup and business realignment to “reignite growth” at the struggling wearables maker, which lostmore than 60% of its market value over the past 12 months. Chief Business Officer Woody Scal andExecutive VP Tim Roberts, who oversaw the company’s social networking efforts, announced that they would step down at the end of March. Scal and Roberts were notably two of Fitbit’s first employees.

  • [By Paul Ausick]

    Fitbit Inc. (NYSE: FIT) dropped about 3.3% on Thursday to record a new 52-week low of $5.62. The stock closed at $5.81 on Wednesday. Volume was about 35% below the daily average of around 11.6 million shares. The company had no news, but the ripples are still spreading from the charges leveled by competitor Jawbone over Fitbit’s theft of trade secrets.

  • [By Trey Thoelcke]

    Fitbit Inc. (NYSE: FIT) is set to release its first-quarter results after the closing bell on Wednesday. The consensus forecast calls for a net loss of $0.20 per share and $247.56 million in revenue. Shares traded on Fridays close at $5.30. The consensus price target is $6.13, and the 52-week range is $4.51 to $7.32.

Top 10 Stocks To Own Right Now: Actuant Corporation(ATU)

Advisors’ Opinion:

  • [By Monica Gerson]

    Actuant Corporation (NYSE: ATU) is projected to report its quarterly earnings at $0.18 per share on revenue of $267.64 million. Actuant shares dropped 3.73 percent to close at $22.98 yesterday.

  • [By Ben Levisohn]

    Flexing the barbell strategy to balance Safe Havens with more cyclical exposures. In our view, industrials investors should be positioning their portfolio with a barbell strategy, with half of the exposure in Safe Havens like General Electric, Xylem (XYL), Danaher, Honeywell International, Roper Technologies (ROP), and AMETEK (AME), and the other half selectively in the cyclical names that are better positioned today, such as Pentair, HD Supply Holdings (HDS),Actuant (ATU), Atkore International Group (ATKR), Ingersoll-Rand, and Eaton (ETN). We still believe risk-reward is mostly balanced and that the macro will remain choppy into 2017, supporting a positioning in the defensive names. But if investor sentiment improves on not-worse news and earnings results, the more cyclical names could fare better.

  • [By Monica Gerson]

    Actuant Corporation (NYSE: ATU) is estimated to report its quarterly earnings at $0.18 per share on revenue of $267.64 million.

    Jabil Circuit, Inc. (NYSE: JBL) is projected to post its quarterly earnings at $0.60 per share on revenue of $4.50 billion.

Top 10 Stocks To Own Right Now: BB&T Corporation(BBT)

Advisors’ Opinion:

  • [By ]

    BB&T Bank (BBT) : “They report next week and I think the story will be a good one. I’d only buy into weakness. It’s still not down enough from it’s high.”

  • [By Ben Levisohn]

    We believe investors should continue to own three types of bank stocks: “Return of Capital (RC) Stocks”, “Risk On (RO) Stocks”, and “Multiple Revaluation (MR) Stocks.” RC stocks include M&T Bank (MTB), PNC Financial Services Group (PNC), and SunTrust Banks (STI); RO stocks include Bank of America, Popular (BPOP), Citigroup, JPMorgan, and KeyCorp (KEY); and MR stocks include BB&T (BBT) and PNC Financial Services Group (PNC).

  • [By ]

    In the Lightning Round, Cramer was bullish on FMC Corp (FMC) , Pennsylvania Real Estate Investment Trust  (PEI) , Cisco Systems (CSCO) , HP (HPQ) , BB&T Bank (BBT) and HCA Holdings (HCA) .

Hot Blue Chip Stocks To Invest In 2018

If you're like most investors, you've been led to believe that it's impossible to earn large amounts of investment income without taking big risks.   This idea – which you'll hear from many financial advisors and brokers – is simply wrong.   It is possible to earn double-digit annual yields on your money – safely – by selling options.   So why doesn't everyone use this strategy to earn consistent income streams? Below, you'll find the five common objections I've heard from readers or that I've found on the Internet… and my responses to them.   REASON NO. 1: Option-selling strategies like covered calls are too risky. You'll earn 5% in premiums, but if the stock falls 25%, you're still down big!   This objection is 100% valid. The way most people approach covered calls is risky. (If you're unfamiliar with covered calls, I encourage you to read this essay.) These folks buy risky stocks because risky, volatile stocks typically offer larger cash premiums than safe, stable blue chips. But most people end up losing on risky covered-call positions because their stocks fall in value.

Hot Blue Chip Stocks To Invest In 2018: The Michaels Companies, Inc.(MIK)

Advisors’ Opinion:

  • [By JPMorgan]

    MIK’s results over the past year point to the company’s success in improving merchandising, marketing, and in-store execution plus the benefits of having a functioning e-commerce website. We believe part of the challenge for the bears is both a lack of appreciation for the category as well as missing the historical context of how leadership has evolved. Indeed, the difference in focus on "the front end" under CEO Chuck Rubin (who arrived in 2013) vs. a more process-oriented and margin-focused CEO prior to his arrival left a lot of impactful, low hanging fruit opportunities. Finally, while we acknowledge that longer term the sustainable comp is lower than the recent ~4% underlying trend, we point to the low volatility of sales, high cash generative nature of the business, barriers to entry (e.g., high SKU density, low inventory turns, lack of brands), and MIK’s market leadership as reasons why the multiple has the potential to expand over time (a la AZO). Balance sheet de-levering should also make the PE look increasingly cheap over time and transfer cash/value to equity holders. 

  • [By Laurie Kulikowski]

    We rate MICHAELS COS INC as a Sell with a ratings score of D+. This is driven by some concerns, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. Among the areas we feel are negative, one of the most important has been weak operating cash flow. 

  • [By Jim Cramer]

    The company, on the basis of net income growth from the same quarter one year ago, has significantly outperformed against the S&P 500 and exceeded that of the Specialty Retail industry average. The net income increased by 20.0% when compared to the same quarter one year prior, going from $64.00 million to $76.80 million.

     

Hot Blue Chip Stocks To Invest In 2018: Prothena Corporation plc(PRTA)

Advisors’ Opinion:

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

Hot Blue Chip Stocks To Invest In 2018: Shenandoah Telecommunications Co(SHEN)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, telecommunications services shares fell by 0.99 percent. Meanwhile, top losers in the sector included Chunghwa Telecom Co., Ltd (ADR) (NYSE: CHT), down 3 percent, and Shenandoah Telecommunications Company (NASDAQ: SHEN), down 4 percent.

  • [By WWW.THESTREET.COM]

    Cramer said that Shenandoah Telecommunications (SHEN) is expensive at 60 times earnings, and without a dividend, he also took a pass on that one.

    Finally, Cramer said Hudson Technologies (HDSN) was a great stock to own in 2016, when shares soared 170%, but this year, he cannot recommend this high-flying refrigeration company.

  • [By Lisa Levin]

    In trading on Monday, telecommunications services shares fell 0.45 percent. Meanwhile, top losers in the sector included Shenandoah Telecommunications Company (NASDAQ: SHEN), down 3 percent, and TIM Participacoes SA (ADR) (NYSE: TSU) down 2 percent.

Hot Blue Chip Stocks To Invest In 2018: Wal-Mart Stores, Inc.(WMT)

Advisors’ Opinion:

  • [By Paul Ausick]

    For the month of November, Boeing stock added about $13.00, a gain of 5%. The Dow’s big gainer last month was Wal-Mart Stores Inc. (NYSE: WMT), up nearly 11% after posting solid earnings and raising fourth-quarter and full-year guidance.

  • [By Paul Ausick]

    There were two big winners in 2017 and three more stocks that posted very solid gains above 40%:

    Boeing Co. (NYSE: BA), up 89% Caterpillar Inc. (NYSE: CAT), up 68.9% Visa Inc. (NYSE: V), up 46.1% Apple Inc. (NASDAQ: AAPL), up 46.1% Wal-Mart Stores Inc. (NYSE: WMT), up 42.9%.

    A stronger global economy contributed to the fortunes of at least two of these firms. while lower U.S. unemployment and improving wages helped the more consumer oriented companies post their gains.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Tuesday was Wal-Mart Stores, Inc. (NYSE: WMT) which rose 4.5% to $84.14. The stocks 52-week range is $65.28 to $84.88. Volume was 34.8 million compared to its average volume of 8.2 million.

Hot Blue Chip Stocks To Invest In 2018: IPG Photonics Corporation(IPGP)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Monday began on a down note for the stock market, as the Dow Jones Industrials fell back down below the 20,000 level. Major market benchmarks finished with losses of 0.6% to 0.8%, and some market commentators attributed the declines to nervousness about the Trump administration’s actions to clamp down on immigration. Others noted that the latest reading of U.S. economic growth showed a 1.9% rise in gross domestic product for the fourth quarter, finishing the year with an overall GDP increase of just 1.6%, down a full percentage point from 2015’s growth. Despite the overall sullen mood in the market, some stocks gained ground, and GoPro (NASDAQ:GPRO), Movado Group (NYSE:MOV), and IPG Photonics (NASDAQ:IPGP) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

Hot Blue Chip Stocks To Invest In 2018: American Electric Power Company, Inc.(AEP)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Masco (MAS) , American Electric Power (AEP) and Valmont Industries (VMI) .

    Cramer was bearish on Wisconsin Energy (WEC) .

  • [By Chris Lange]

    American Electric Power Company, Inc. (NYSE: AEP) shares were recently up 2.5% at $64.93, with a 52-week range of $62.69 to $78.07 and a consensus price target of $74.00.